155 related articles for article (PubMed ID: 9424009)
1. Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay.
McLaren DB; Pickles T; Thomson T; Olive PL
Radiother Oncol; 1997 Nov; 45(2):175-82. PubMed ID: 9424009
[TBL] [Abstract][Full Text] [Related]
2. Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia.
Aquino-Parsons C; Luo C; Vikse CM; Olive PL
Radiother Oncol; 1999 May; 51(2):179-85. PubMed ID: 10435811
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in human tumour hypoxic fraction using the comet assay.
Olive PL; Trotter T; Banáth JP; Jackson SM; Le Riche J
Br J Cancer Suppl; 1996 Jul; 27():S191-5. PubMed ID: 8763878
[TBL] [Abstract][Full Text] [Related]
4. Reduction of tumor hypoxia and inhibition of DNA repair by nicotinamide after irradiation of SCCVII murine tumors and normal tissues.
Zheng H; Olive PL
Cancer Res; 1996 Jun; 56(12):2801-8. PubMed ID: 8665517
[TBL] [Abstract][Full Text] [Related]
5. ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.
Bernier J; Denekamp J; Rojas A; Trovò M; Horiot JC; Hamers H; Antognoni P; Dahl O; Richaud P; Kaanders J; van Glabbeke M; Piérart M
Radiother Oncol; 1999 Aug; 52(2):149-56. PubMed ID: 10577700
[TBL] [Abstract][Full Text] [Related]
6. A pilot study comparing intratumoral oxygenation using the comet assay following 2.5% and 5% carbogen and 100% oxygen.
Partridge SE; Aquino-Parsons C; Luo C; Green A; Olive PL
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):575-80. PubMed ID: 11173157
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.
Horsman MR
Acta Oncol; 1995; 34(5):571-87. PubMed ID: 7546822
[TBL] [Abstract][Full Text] [Related]
8. The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
Stüben G; Stuschke M; Knühmann K; Horsman MR; Sack H
Radiother Oncol; 1998 Aug; 48(2):143-8. PubMed ID: 9783885
[TBL] [Abstract][Full Text] [Related]
9. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
Horsman MR; Nordsmark M; Khalil AA; Hill SA; Chaplin DJ; Siemann DW; Overgaard J
Acta Oncol; 1994; 33(4):371-6. PubMed ID: 8018368
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.
Bernier J; Stratford MR; Denekamp J; Dennis MF; Bieri S; Hagen F; Kocagöncü O; Bolla M; Rojas A
Radiother Oncol; 1998 Aug; 48(2):123-33. PubMed ID: 9783883
[TBL] [Abstract][Full Text] [Related]
11. The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo.
Horsman MR; Wood PJ; Chaplin DJ; Brown JM; Overgaard J
Radiother Oncol; 1990 May; 18(1):49-57. PubMed ID: 2141694
[TBL] [Abstract][Full Text] [Related]
12. Measuring hypoxia in solid tumours--is there a gold standard?
Olive PL; Banáth JP; Aquino-Parsons C
Acta Oncol; 2001; 40(8):917-23. PubMed ID: 11845955
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two techniques for detecting tumour hypoxia: a fluorescent immunochemical method and an in vitro colony assay.
Stern S; Hodgkiss RJ; Guichard M
Radiother Oncol; 1996 May; 39(2):129-35. PubMed ID: 8735480
[TBL] [Abstract][Full Text] [Related]
14. The comet assay in clinical practice.
Olive PL; Durand RE; Jackson SM; Le Riche JC; Luo C; Ma R; McLaren DB; Aquino-Parsons C; Thomson TA; Trotter T
Acta Oncol; 1999; 38(7):839-44. PubMed ID: 10606413
[TBL] [Abstract][Full Text] [Related]
15. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
Chaplin DJ; Horsman MR; Siemann DW
Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
[TBL] [Abstract][Full Text] [Related]
16. Reoxygenation in a C3H mouse mammary carcinoma. The importance of chronic rather than acute hypoxia.
Horsman MR; Grau C; Overgaard J
Acta Oncol; 1995; 34(3):325-8. PubMed ID: 7779417
[TBL] [Abstract][Full Text] [Related]
17. Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay.
Olive PL; Horsman MR; Grau C; Overgaard J
Br J Cancer; 1997; 76(6):694-9. PubMed ID: 9310232
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
Chaplin DJ; Horsman MR; Aoki DS
Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
el-Said A; Menke D; Dorie MJ; Brown JM
Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
[TBL] [Abstract][Full Text] [Related]
20. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.
Kaanders JH; Pop LA; Marres HA; Liefers J; van den Hoogen FJ; van Daal WA; van der Kogel AJ
Radiother Oncol; 1998 Aug; 48(2):115-22. PubMed ID: 9783882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
